Navigate Regulatory Complexity with Confidence
Navigate complex regulatory landscapes with expert guidance across pharmaceuticals, medical devices, and IVD.
Read more订阅生命科学领域的最新动态
专家观点直达您的收件箱——选择您的兴趣。
绝无垃圾邮件。随时取消订阅。
The New Rules for Monitoring Critical Medicines: Safeguarding Europe's Medicine Supply
Discover how the EU’s Critical Medicines Act and ESMP aim to prevent drug shortages and build a resilient medicine supply for Europe’s future.
Keep reading
Related articles
Regulatory Affairs2026年5月6日
Governance in Combined Studies: Getting Roles Right Before the Clock Starts
Discover why governance and role clarity are critical in combined drug-diagnostic studies under the CTR and IVDR.
阅读更多
Regulatory Affairs2026年5月6日
Why Pharma and IVD Partners Must Collaborate Earlier Than You Think
Discover why early collaboration between pharma sponsors and IVD partners is critical for successful companion diagnostic development under the IVDR.
阅读更多
Regulatory Affairs2026年5月6日
No Shortcuts: Why In-House Devices Under Article 5(5) Are Not the Easy Route
Thinking Article 5(5) is the easy route under the IVDR? Discover the hidden obligations and risks of in-house devices.
阅读更多